Mon panier

Human LPAR1 Full Length Protein (VLP)

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
LP1-H52P3-20ug
$620.00
LP1-H52P3-100ug
$1235.00
LP1-H52P3-500ug (250ug X 2)
$4305.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Application

    1. Immunization
    2. Cell based assay (FACS or functional assay)
    3. Screening (ELISA)
  • Synonyms

    EDG2, Gpcr26, LPA1, Mrec1.3, VZG1, edg-2, rec.1.3, vzg-1

  • Source

    Human LPAR1 Full Length Protein (VLP) (LP1-H52P3) is expressed from human 293 cells (HEK293). It contains AA Ala 2 - Val 364 (Accession # Q92633).

    Predicted N-terminus: Asp

  • Molecular Characterization

    *The isotype control of empty/mock VLP (Cat. No. VLP-N5213) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Virus-like particles (VLPs) are protein particles that mimic the shape of viruses but lack a viral genome, and incorporating transmembrane proteins on the external surface.

    2. Synthesis Process

      Envelope virus-like particles (eVLPs) are produced by co-expressing target membrane proteins with viral structural proteins in mammalian cells, enabling native embedding of membrane proteins into the lipid bilayer during VLP budding. This approach preserves authentic conformation, post-translational modifications, and orientation, while creating a completely detergent-free environment with repetitive multivalent display and strong immunogenicity making them ideal for immunization, binding assays in antibody discovery and screening (ELISA), and cell-based assays such as FACS, etc.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Formulation

    The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).

    Supplied as 0.2 μm filtered solution in PBS, Arginine, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 12 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • Bioactivity-ELISA

     LPAR1 ELISA

    Immobilized Human LPAR1 Full Length Protein (VLP) (Cat. No. LP1-H52P3) at 5 μg/mL (100 μL/well) can bind Anti-LPAR1 Antibody, Human IgG1 with a linear range of 0.2-4 ng/mL (QC tested).

    Protocol
  • Identity-DLS

     LPAR1 DLS

    The mean peak Radius of VLP is 65-85 nm with more than 95% intensity as determined by dynamic light scattering (DLS).

Avis des utilisateurs
Publier un commentaire

Introduction de fond

Lysophosphatidic Acid Receptor 1, a GPCR mediating fibrosis, vasoconstriction, and neuropathic pain. It is a genetically and pharmacologically validated target for Idiopathic Pulmonary Fibrosis (IPF) and Systemic Sclerosis. Antagonists aim to halt fibroblast migration and collagen deposition in progressive fibrotic diseases.

Progrès de frontière

 
Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs
  • Contexte